Effects of Chest Physiotherapy on Quality of Life in COVID-19 Patients
DOI:
https://doi.org/10.55735/hjprs.v3i5.342Keywords:
Chest physiotherapy, COVID-19, Pandemic, Quality of lifeAbstract
Background: COVID-19 has affected the population badly in the respiratory system. To overcome this, chest physiotherapy has been proven to be an effective treatment option for these patients. Objective: To determine the effects of chest physiotherapy on the quality of life in COVID-19 patients. Methodology: Data was collected from COVID-19 patients in the University of Lahore Teaching Hospital, Central Park Teaching Hospital, Jinnah Hospital, and Doctor Hospital. This cross-sectional observational study was conducted on 106 COVID-19 patients who had undergone chest physiotherapy sessions during their hospital stay. The data was collected within 6 months, i.e., May 2022 to December 2022. The sample size was selected using a non-probability, convenience sampling technique. All the patients who met the inclusion criteria, like those aged between 35 to 65 years, both males and females, patients infected with COVID, patients who took chest physiotherapy sessions, and hospitalized patients. A sample size of 106 was calculated with a 95% confidence level by using Epitool. For the collection of the data, a WHO-QoL Questionnaire and a researcher-designed questionnaire were used, which consisted of demographic information and questions regarding length of hospital stay, COVID symptoms experienced, and chest physiotherapy. Written consent was taken from the participants, and the quantitative variables were presented as mean and standard deviation, range, and histogram. Categorical variables were presented as frequencies, percentages, cross-tabulation, bar chart, and pie chart. Results: During their hospital stay, 60 (60.4%) of the patients received chest physical therapy. After receiving chest physiotherapy, 28.3% of the patients reported an improvement in their quality of life. 35 (33%) patients were female, while 71 (67%) of the total participants were male. Conclusion: During their time in the hospital, 60.4 percent of COVID patients received chest physical therapy. About 28.3% of the patients reported a higher and enhanced quality of life as a result of the chest physiotherapy procedures following the procedure during their hospital stay and after recovering from COVID-19. While chest physiotherapy techniques increased 30.5% of the recovered patients’ capacity to do daily activities.
Downloads
References
Righetti RF, Onoue MA, Politi FVA, Teixeira DT, Souza PNd, Kondo CS, et al. Physiotherapy care of patients with coronavirus disease 2019 (covid-19)-a Brazilian experience. 2020;75. DOI: https://doi.org/10.6061/clinics/2020/e2017
Al Chikhanie Y, Veale D, Schoeffler M, Pépin J, Verges S, Hérengt FJRP, et al. Effectiveness of pulmonary rehabilitation in COVID-19 respiratory failure patients post-ICU. 2021;287:103639. DOI: https://doi.org/10.1016/j.resp.2021.103639
Perna G, Cuniberti F, Daccò S, Nobile M, Caldirola D. Impact of respiratory protective devices on respiration: Implications for panic vulnerability during the COVID-19 pandemic. Journal of Affective Disorders. 2020 Dec 1;277:772-8. DOI: https://doi.org/10.1016/j.jad.2020.09.015
Rizvi MAR, Simon NH. Effects of Respiratory Therapy and Physical Rehabilitation in a Reduction of Length of ICU Stay among Covid-19 Patients–A Narrative Review.
Serresse L, Simon-Tillaux N, Decavèle M, Gay F, Nion N, Lavault S, Guerder A, Châtelet A, Dabi F, Demoule A, Morélot-Panzini C. Lifting dyspnoea invisibility: COVID-19 face masks, the experience of breathing discomfort, and improved lung health perception–a French nationwide survey. European Respiratory Journal. 2022 Mar 1;59(3). DOI: https://doi.org/10.1183/13993003.01459-2021
Liu CH, Stevens C, Conrad RC, Hahm HC. Evidence for elevated psychiatric distress, poor sleep, and quality of life concerns during the COVID-19 pandemic among US young adults with suspected and reported psychiatric diagnoses. Psychiatry Research. 2020 Oct 1;292:113345. DOI: https://doi.org/10.1016/j.psychres.2020.113345
Yang L-L, Yang TJCd, medicine t. Pulmonary rehabilitation for patients with coronavirus disease 2019 (COVID-19). 2020. DOI: https://doi.org/10.1016/j.cdtm.2020.05.002
Kalirathinam D, Guruchandran R, Subramani P. Comprehensive physiotherapy management in COVID-19–a narrative review. Scientia Medica. 2020 May 26;30(1):e38030-. DOI: https://doi.org/10.15448/1980-6108.2020.1.38030
Battaglini D, Robba C, Caiffa S, Ball L, Brunetti I, Loconte M, et al. Chest physiotherapy: an important adjuvant in critically ill mechanically ventilated patients with COVID-19. 2020:103529. DOI: https://doi.org/10.1016/j.resp.2020.103529
Medrinal C, Prieur G, Bonnevie T, Gravier FE, Mayard D, Desmalles E, Smondack P, Lamia B, Combret Y, Fossat G. Muscle weakness, functional capacities and recovery for COVID-19 ICU survivors. BMC Anesthesiology. 2021 Dec;21:1-5. DOI: https://doi.org/10.1186/s12871-021-01274-0
Kader M, Hossain MA, Reddy V, Perera NK, Rashid M. Effects of short-term breathing exercises on respiratory recovery in patients with COVID-19: a quasi-experimental study. BMC Sports Science, Medicine and Rehabilitation. 2022 Apr 5;14(1):60. DOI: https://doi.org/10.1186/s13102-022-00451-z
Lalwani L, Mishra G, Gaidhane A, Quazi N, Taksande AJTOPHJ. Chest Physiotherapy in Patients Admitted to the Intensive Care Unit With COVID-19: A Review. 2021;14(1). DOI: https://doi.org/10.2174/1874944502114010145
Kress JP, Hall JBJNEJoM. ICU-acquired weakness and recovery from critical illness. 2014;370(17):1626-35. DOI: https://doi.org/10.1056/NEJMra1209390
Barda N, Dagan N, Ben-Shlomo Y, et al. Safety of the BNT162b2 mRNA COVID-19 vaccine in a nationwide setting. N Engl J Med 2021.Epub August 25, 2021. PMID: 34432976 https://doi.org/10.1056/NEJMoa2110475 DOI: https://doi.org/10.1056/NEJMoa2110475
Stahlmann R, Lode H. Medication for COVID-19—an overview of approaches currently under study. Deutsches Ärzteblatt International. 2020 Mar;117(13):213. DOI: https://doi.org/10.3238/arztebl.2020.0213
Aygün İ, Kaya M, Alhajj R. Identifying side effects of commonly used drugs in the treatment of COVID-19. Scientific Reports. 2020 Dec 9;10(1):21508. DOI: https://doi.org/10.1038/s41598-020-78697-1
Bilbul M, Paparone P, Kim AM, Mutalik S, Ernst CL. Psychopharmacology of COVID-19. Psychosomatics. 2020 Sep 1;61(5):411-27. DOI: https://doi.org/10.1016/j.psym.2020.05.006
Raveendran A, Jayadevan R, Sashidharan SJD, Research MSC, Reviews. Long COVID: an overview. 2021. DOI: https://doi.org/10.1016/j.dsx.2021.04.007
Tenforde MW, Kim SS, Lindsell CJ, Rose EB, Shapiro NI, Files DC, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network—United States, March–June 2020. 2020;69(30):993. DOI: https://doi.org/10.15585/mmwr.mm6930e1
Abdullahi A. Safety and Efficacy of Chest Physiotherapy in Patients With COVID-19: A Critical Review. 2020;7(454). DOI: https://doi.org/10.3389/fmed.2020.00454

Downloads
Published
License
Copyright (c) 2023 The Healer Journal of Physiotherapy and Rehabilitation Sciences

This work is licensed under a Creative Commons Attribution 4.0 International License.